Yuan, P., Chen, Z., Cai, L., Fu, F., Ouyang, Q., Li, M., Liu, S., Shi, Y., Wang, W., Ji, X., Zhai, Z., Ju, F., Wu, J., Zhou, Y., Yin, Y., Ouyang, Z., Yi, W., Liu, H., Yang, Y., Jiang, Z. (2026). Capivasertib plus fulvestrant in Chinese patients with HR+/HER2− advanced breast cancer: Interim analysis of CAPItrue.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1088